Second hot round of impotence drug markets.

Celebrating the 5th year and 1st year anniversaries for Viagra and the followers like Levitra and Cialis, they are now getting into the second round of the market competition that seemed to be far sharp struggles than the first round because they thought once the fight failed the aftermath likely to be firmly fixed.

In fact, it is estimated that only 10% out of the total impotence patients ...